Real-Life ILUVIEN (Fluocinolone Acetonide) Case Study: Rapid Drying of the Macula and Improved Vision within 2 Years after Therapy Initiation

IMPORTANCE: A case showing sustained structural and functional responses 2 years after a single treatment with ILUVIEN (0.2 µg/day fluocinolone acetonide, FAc) despite suboptimal responses to ranibizumab. OBSERVATIONS: A 68-year-old female patient with diabetic macular oedema (DME) from type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Quhill, Hibba, Quhill, Fahd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260609/
https://www.ncbi.nlm.nih.gov/pubmed/28203186
http://dx.doi.org/10.1159/000452883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260609/
https://www.ncbi.nlm.nih.gov/pubmed/28203186
http://dx.doi.org/10.1159/000452883

Ejemplares similares